Login to Your Account



Pieris, Daiichi Sankyo Ink Anticalins Deal for up to $296M

By Cormac Sheridan


Wednesday, April 13, 2011
Pieris AG is banking 7 million (US$10.1 million) up front and could earn up to 200 million more in milestone payments and research funding from a discovery deal with Daiichi Sankyo, based around its anticalin protein scaffold technology.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription